SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001104659-23-067886
Filing Date
2023-06-05
Accepted
2023-06-05 08:54:08
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFM14A tm2316342-3_defm14a.htm DEFM14A 2486095
2 GRAPHIC ft_centerviewpartners-bwlr.jpg GRAPHIC 45111
3 GRAPHIC hd_bankofamericaglobal-4clr.jpg GRAPHIC 65881
4 GRAPHIC lg_bankofamerica-4clr.jpg GRAPHIC 15827
5 GRAPHIC lg_centerviewpartners-bwlr.jpg GRAPHIC 17513
6 GRAPHIC px_ivericbioproxy1pg01-4c.jpg GRAPHIC 1076253
7 GRAPHIC px_ivericbioproxy1pg02-4c.jpg GRAPHIC 672979
8 GRAPHIC sg_bofasecuritiesinc-bw.jpg GRAPHIC 17283
9 GRAPHIC sg_centerviewpartnersllc-4c.jpg GRAPHIC 21970
  Complete submission text file 0001104659-23-067886.txt   4906018
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-36080 | Film No.: 23991361
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences